Ares Management\u2019s Asia private equity arm has entered Vietnam\u2019s healthcare market through an investment in Medlatec Group. While financial terms of the deal were not disclosed, Medlatec called Ares a \u201cstrategic investor\u201d in a statement.<\/p>\n
The Vietnamese company said that by leveraging the $572-billion investment firm\u2019s global network, it aims to accelerate digital transformation and strengthen its competitiveness in the local market.<\/p>\n
The company currently operates one hospital, nine clinics, along with labs, diagnostic imaging centres, home sampling services, and the MyMedlatec digital platform. According to latest regulatory filings, the Hanoi-headquartered business\u2019 charter capital stands at almost $50 million.<\/p>\n
The new capital will support the development of AI-driven solutions for diagnosis and treatment, as well as the expansion of its hospital and laboratory network across Vietnam.<\/p>\n
Last year, DealStreetAsia reported<\/a> that Medlatec was looking to raise capital in the lower $100-million range. By then, Ares and Quadria were understood to evaluate the opportunity. In August 2025, Mergermarket reported that Ares picked a 30% stake in Medlatec for $150 million.<\/p>\n The transaction marks Ares\u2019s foray into Vietnam\u2019s healthcare space, though the firm is already active in the country with investments in several resorts; and children\u2019s lifestyle platform NKid, a portfolio it inherited<\/a> from Crescent Point Capital.<\/p>\n Despite a challenging investment environment, healthcare remains an attractive sector for major private equity players. Quadria Capital recently acquired Tam Tri Medical<\/a>, following its earlier deal with Con Cung and past investment in FV Hospital.<\/p>\n Nhi Dong 315 has raised nearly $200 million<\/a> from investors including GIC, while Mekong Capital also made its first hospital investment in TNH Hospital<\/a> earlier this year.<\/p>\n Notably, big-ticket deals are diversifying beyond hospital assets towards a more consumer-driven healthcare model.<\/p>\n